A similar improved anti-EPX+ eosinophil accumulation, protein expression, and associated improved pathological characteristics such as improved tissue fibrosis and ADM was observed in cerulein-with-AOM–treated IL-18 gene–deficient mice compared with wild-type mice (Fig 6A–G). The gene discussed is IL18; the disease is infectious otitis media.